510(k) K081674
K081674 is an FDA 510(k) premarket notification submitted by The Binding Site, Ltd. for the device "BINDAZYME HUMAN ANTI-GLIADIN (MGP), IGG EIA KIT; BINDAZYME HUMAN ANTI-GLIADIN (MGP) IGA EIA KIT; (IGA OR IGG)". The FDA issued a decision of Substantially Equivalent on October 15, 2008. The device falls under product code MST (Antibodies, Gliadin), a Class II device regulated under 21 CFR 866.5750. The Binding Site, Ltd. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- October 15, 2008
- Date Received
- June 17, 2008
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Antibodies, Gliadin
- Device Class
- Class II
- Regulation Number
- 866.5750
- Review Panel
- IM
- Submission Type